Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker’s immunology pipeline.
Related Posts
Super-Star Sneaker Maker Golden Goose Postpones IPO
Italian fashion company Golden Goose, the maker of Super-Star sneakers worn by celebrities including Taylor Swift, has postponed its initial public offering, citing European market […]
Corporate Retreats Are Back. Hotels Are Banking on It.
Desire for more face-to-face meetings is spurring companies to book group events.
Volvo Trims Profit Outlook
Carmaker Volvo cut its earnings expectations for 2025, citing complex market conditions and uncertainty around worldwide trade wars.